Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Life Nova+ (Site 1203)

Forbach, Pamplemousses District 21014, MauritiusNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Type 2 diabetes

Closed trials

Completed
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
NCT04029480· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Life Nova+ (Site 1203): trial site – Frontlight Research